Conti Angela A - OmicsDI

Show results for

Proteomics (4)
Genomics (3)
Transcriptomics (2)
Metabolomics (2)
Unknown (1)

Organisms

Homo sapiens (9)

Repository

pride (4)
EGA (3)
biostudies-arrayexpress (2)
MetaboLights (2)

Tissue

Malignant cell (3)
Fibroblast (1)

Technology Type

Data-dependent acquisition (4)
Data-independent acquisition (4)
Mass Spectrometry (4)
Mass spectrometry (2)
Illumina OncoArray (1)

Instrument Platform

Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - hilic (1)
Liquid Chromatography MS - positive - reverse phase (1)
Q Exactive (1)

Publication Date

2026 (4)
2022 (2)
2014 (1)
2009 (1)

CHEBI ID

CHEBI:15428 (2)
CHEBI:15611 (2)
CHEBI:15698 (2)
CHEBI:15728 (2)
CHEBI:15891 (2)
CHEBI:15978 (2)
CHEBI:15999 (2)
CHEBI:16020 (2)
CHEBI:16199 (2)
CHEBI:16335 (2)
CHEBI:16359 (2)
CHEBI:16450 (2)
CHEBI:16530 (2)
CHEBI:16628 (2)
CHEBI:16668 (2)
CHEBI:16675 (2)
CHEBI:16704 (2)
CHEBI:16708 (2)
CHEBI:16737 (2)
CHEBI:16750 (2)
CHEBI:16827 (2)
CHEBI:16919 (2)
CHEBI:17012 (2)
CHEBI:17050 (2)
CHEBI:17140 (2)
CHEBI:17154 (2)
CHEBI:17172 (2)
CHEBI:172453 (2)
CHEBI:17287 (2)
CHEBI:17385 (2)

Metabolite Name

O-Tyrosine (2)
(R)-3-hydroxybutyrylcarnitine (1)
1,11-Undecanedicarboxylic acid (1)
1,3-Dimethyluric acid (1)
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)* (1)
1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)* (1)
1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1)* (1)
1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0)* (1)
1-(1-enyl-palmitoyl)-GPE (P-16:0)* (1)
1-(1-enyl-stearoyl)-GPE (P-18:0)* (1)
1-arachidonoyl-GPI (20:4)* (1)
1-lignoceroyl-GPC (24:0) (1)
1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6)* (1)
1-linoleoyl-GPC (18:2) (1)
1-linoleoyl-GPE (18:2)* (1)
1-methyl-4-imidazoleacetate (1)
1-methylguanidine (1)
1-methylhistamine (1)
1-methylhistidine (1)
1-methylnicotinamide (1)
1-myristoyl-2-palmitoyl-GPC (14:0/16:0) (1)
1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6)* (1)
1-oleoyl-2-linoleoyl-GPE (18:1/18:2)* (1)
1-oleoyl-GPI (18:1) (1)
1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* (1)
1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) (1)
1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6)* (1)
1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) (1)
1-palmitoyl-2-oleoyl-GPC (16:0/18:1) (1)
1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1)* (1)

Study type

Transcription profiling by array (2)

Release Date

2014 (1)
2009 (1)
2023 (1)

Lab affiliation

IFOM (4)

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma (Xenograft assays)

Glioblastoma (GBM) is a common and deadly form of brain tumor in adults. Dysregulated metabolism in GBM offers an opportunity to deploy metabolic interventions as precise therapeutic strategies. To identify the molecular drivers and the modalities by which different molecular subgroups of GBM exp...

2022-11-08 | MTBLS730 | MetaboLights

Aberrant L-Fucose accumulation and increased core fucosylation are metabolic liabilities in mesenchymal glioblastoma (Stem cell and cell line assays)

2022-11-08 | MTBLS4708 | MetaboLights

BACE2 and lipid metabolism (DMSO versus BACE2i 3I proteomic analysis)

proteomic analysis of melanoma, PDAC cells and fibroblast treated with DMSO vs 3I

ORGANISM(S): Homo sapiens (Human)

2026-02-09 | PXD058789 | Pride

Bace2 lipid metabolism

BACE2 and lipid metabolism (spatial proteomics)

spatial proteomic analysis of malanoma IGR37 cell lines

ORGANISM(S): Homo sapiens (Human)

2026-02-09 | PXD058731 | Pride

Bace2 lipid metabolism

BACE2 and lipid metabolism (SSO treatment plus BACE2i time couse proteomic analysis)

SSO treatment and BACe2i time couse proteomic analysis in melanoma IGR37 cell lines

ORGANISM(S): Homo sapiens (Human)

2026-02-09 | PXD058751 | Pride

Bace2 lipid metabolism

BACE2 and lipid metabolism (global proteomic analysis)

global proteomic analysis of melanoma cell lines expressing different bace2 levels

ORGANISM(S): Homo sapiens (Human)

2026-02-09 | PXD058702 | Pride

Bace2 lipid metabolism cancer

Gene expression profile in human orthotopic liver transplantation

We have studied the genes activated in human liver transplantation to identify potential target genes for the prevention or treatment of related injuries. In a first protocol, in order to evaluate the effect of Ischemia-Reperfusion Injury (IRI) on gene expression profile, we compared gene expressio...

ORGANISM(S): Homo sapiens

2009-10-01 | E-GEOD-14951 | biostudies-arrayexpress

The Ovarian Cancer Association Consortium OncoArray genome-wide association study

A custom Illumina genotyping array, the OncoArray. The array includes a genome-wide backbone, comprising 230,000 SNPs tagging most common genetic variants, together with dense mapping of known susceptibility regions, rare variants from sequencing experiments, pharmacogenetic markers, and cancer-rela...

EGAS00001002305 | EGA

Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity

Recessive dystrophic epidermolysis bullosa (RDEB) is a genodermatosis characterized by fragile skin forming blisters that heal invariably with scars. It is due to mutations in the COL7A1 gene encoding type VII collagen, the major component of anchoring fibrils connecting the cutaneous basement membr...

ORGANISM(S): Homo sapiens

2014-04-03 | E-GEOD-51056 | biostudies-arrayexpress

OCAC OncoArray data

Germline genotype data on 56,479 ovarian cancer cases and controls

EGAD00010001192 | EGA

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

12 Results

Show results for

Organisms

Repository

Tissue

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets